Get Social With Us

Single-Use technology and modular construction: Enabling biopharmaceutical facilities of the future

By: Levine HL, et al
Reprinted with the permission of BioProcess International, April 2013

Following our overview of the drivers for more flexible and economic facility options for biopharmaceutical manufacturing, we present here an economic model for efficient monoclonal antibody manufacturing using single use technologies. These technologies, coupled with modular advances in modular facility design and construction, are driving the construction of local state‑of‑the‑art manufacturing facilities to provide local and regional manufacturing capabilities.